Holdings of Remedium Capital Partners, LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 5 in 1 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Oruka Therapeutics Inc | 1,565,661 | 76.8M $ | |
| 2 | Spyre Therapeutics Inc | 1,456,231 | 73.5M $ | |
| 3 | DAMORA THERAPEUTICS INC | 2,045,473 | 53M $ | |
| 4 | Apogee Therapeutics Inc | 583,591 | 49.1M $ | |
| 5 | JADE BIOSCIENCES INC | 1,577,750 | 22.2M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 100.0 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 5 | 274.5M $ | 100.00 % |
Cite this page
Titelia. "Holdings of Remedium Capital Partners, LLC". https://titelia.com/en/funds/US13F2104501